BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30648522)

  • 1. Synthesis and Screening of Pro-apoptotic and Angio-inhibitory Activity of Novel Benzisoxazole Derivatives both In Vitro and In Vivo.
    Byrappa S; Rachaiah K; Kotian SY; Balaraju Y; Prabhuswamimath SC; Rai KML; Salimath BP
    Anticancer Agents Med Chem; 2019; 19(6):827-839. PubMed ID: 30648522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of some novel methyl β-orsellinate based 3, 5-disubstituted isoxazoles and their anti-proliferative activity: Identification of potent leads active against MCF-7 breast cancer cell.
    Reddy ST; Mendonza JJ; Makani VKK; Bhadra MP; Uppuluri VM
    Bioorg Chem; 2020 Dec; 105():104374. PubMed ID: 33130349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Novel 4-Phenyl-2-Phenoxyacetamide Thiazoles modulates the tumor hypoxia leading to the crackdown of neoangiogenesis and evoking the cell death.
    Mohammed YHE; Malojirao VH; Thirusangu P; Al-Ghorbani M; Prabhakar BT; Khanum SA
    Eur J Med Chem; 2018 Jan; 143():1826-1839. PubMed ID: 29133037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.
    Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S
    Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of isoxazole analogs: Synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids, and molecular modeling.
    Hawash M; Abdallah S; Abudayyak M; Melhem Y; Abu Shamat M; Aghbar M; Çapan I; Abualhasan M; Kumar A; Kamiński M; Góral T; Dominiak PM; Sobuh S
    Eur J Med Chem; 2024 May; 271():116397. PubMed ID: 38626522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives as antiproliferative agents: a structure-activity relationship study.
    Benaka Prasad SB; Vinaya K; Ananda Kumar CS; Swarup S; Rangappa KS
    Invest New Drugs; 2009 Dec; 27(6):534-42. PubMed ID: 19066725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
    Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
    Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in vivo.
    Luo K; Bao Y; Liu F; Xiao C; Li K; Zhang C; Huang R; Lin J; Zhang J; Jin Y
    Eur J Med Chem; 2019 Oct; 179():805-827. PubMed ID: 31295714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors.
    Im D; Jung K; Yang S; Aman W; Hah JM
    Eur J Med Chem; 2015 Sep; 102():600-10. PubMed ID: 26318067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships of asymmetric dimeric β-carboline derivatives as potential antitumor agents.
    Guo L; Chen W; Cao R; Fan W; Ma Q; Zhang J; Dai B
    Eur J Med Chem; 2018 Mar; 147():253-265. PubMed ID: 29448140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative novel isoxazoles: modeling, virtual screening, synthesis, and bioactivity evaluation.
    Tzanetou E; Liekens S; Kasiotis KM; Melagraki G; Afantitis A; Fokialakis N; Haroutounian SA
    Eur J Med Chem; 2014 Jun; 81():139-49. PubMed ID: 24836066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel triazoles and isoxazoles linked 2-phenyl benzothiazole as potential anticancer agents.
    Kumbhare RM; Kosurkar UB; Janaki Ramaiah M; Dadmal TL; Pushpavalli SN; Pal-Bhadra M
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5424-7. PubMed ID: 22858144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regioselective synthesis of 3,4-diaryl-5-unsubstituted isoxazoles, analogues of natural cytostatic combretastatin A4.
    Chernysheva NB; Maksimenko AS; Andreyanov FA; Kislyi VP; Strelenko YA; Khrustalev VN; Semenova MN; Semenov VV
    Eur J Med Chem; 2018 Feb; 146():511-518. PubMed ID: 29407976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
    Zhou P; Huang L; Zhou J; Jiang B; Zhao Y; Deng X; Zhao Q; Li F
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4185-4189. PubMed ID: 28757067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hollongdione arylidene derivatives induce antiproliferative activity against melanoma and breast cancer through pro-apoptotic and antiangiogenic mechanisms.
    Smirnova I; Drăghici G; Kazakova O; Vlaia L; Avram S; Mioc A; Mioc M; Macaşoi I; Dehelean C; Voicu A; Şoica C
    Bioorg Chem; 2022 Feb; 119():105535. PubMed ID: 34906859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
    Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
    Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level.
    Zhang L; Liu P; Jiang Y; Fan D; He X; Zhang J; Luo B; Sui J; Luo Y; Fu X; Yang T
    Eur J Med Chem; 2024 Jun; 272():116448. PubMed ID: 38704936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel forskolin isoxazole derivatives with potent anti-cancer activity against breast cancer cell lines.
    Burra S; Voora V; Rao CP; Vijay Kumar P; Kancha RK; David Krupadanam GL
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4314-4318. PubMed ID: 28838692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
    Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
    Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and SAR studies of novel 6,7,8-substituted 4-substituted benzyloxyquinolin-2(1H)-one derivatives for anticancer activity.
    Chen YF; Lin YC; Morris-Natschke SL; Wei CF; Shen TC; Lin HY; Hsu MH; Chou LC; Zhao Y; Kuo SC; Lee KH; Huang LJ
    Br J Pharmacol; 2015 Mar; 172(5):1195-221. PubMed ID: 25363404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.